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Editorial on the Research Topic
Gluten, From Plant to Plate: Implications for People With Celiac Disease
Gluten is the collective name for a class of proteins found in wheat, rye, and barley. Eating gluten
triggers an autoimmune reaction in the∼70 million people globally affected by celiac disease (CD),
which causes the gut to react to gluten with intestinal inflammation and epithelial cell damage. In
addition, wheat proteins may trigger respiratory, skin or food allergies and non-celiac gluten/wheat
sensitivity (NCGS). Recently, more and more evidence has been emerging to support an increasing
prevalence of gluten-related disorders in the population. This increase in prevalence has been too
quick to be explained by genetic drift, pointing toward a change in environmental exposures as
risk modifiers.
Gluten-free (GF) foods are now commonplace, offering consumers greater choice and
availability. While many of these foods are made from non-gluten-containing grains,
contamination of these inherently gluten-free products can occur during harvest, transport,
or processing. Moreover, these foods are expensive and may be nutritionally inferior to
gluten-containing products. The differences in nutritional properties of GF foods has led to research
on ways to remove or reduce gluten from wheat and barley to provide new fiber, mineral, and
vitamin options for those whomust avoid gluten. This has led to research in classical plant breeding
and the use of gene technology. An alternative approach to producing celiac-safe foods is via
processing, wherein processes, such as separation, filtration, and/or application of enzymes, aim
to remove gluten from gluten-containing ingredients. With many of these processed products
entering the market, questions remain over the safety of these products and controversy over a
suitable test to determine the gluten content remains. The question why an increasing number
of people are affected by gluten-related disorders also needs to be answered. While improved
diagnostics and awareness may partly explain the rise, further factors such as the use of vital wheat
gluten in many food products, changes in wheat processing and in wheat protein composition
may be responsible. In addition, it has been proposed that other environmental factors such as
introduction of gluten to infant diets, breastfeeding patterns, alterations in the gut microbiota and
infections could also dictate the development of gluten-related disorders.
This e-book is a compilation of 15 research and/or review papers written by 70 authors. This
Special Research Topic comprises contributions from leading experts in the fields of plant breeding,
food processing, clinical immunology, and gluten analysis to share their latest findings and help
improve the quality and safety of foods for CD patients and other gluten-related disorders.
As critical overviews of the field, Shewry reviews wheat gluten, focusing on functional properties,
and its role in triggering coeliac disease and gluten-related disorders. Wieser et al. provide a
Colgrave et al. Editorial: Gluten, From Plant to Plate
balanced review on the benefits of wheat consumption contrasted
with the adverse effects for individuals suffering from wheat-
related disorders.
Starting with the plant, Tanner et al. examined the
accumulation of hordein storage proteins in developing barley
grains using a combination of enzyme-linked immunosorbent
assay (ELISA), western blot and liquid chromatography tandem
mass spectrometry (LC-MS/MS) demonstrating maximum
protein accumulation late in grain development. Shifting to
wheat, Altenbach, Chang, Yu et al. described the genetic
transformation of bread wheat to reduce the omega-1,2 gliadins,
the wheat gluten proteins that present immunodominant
epitopes relevant in celiac disease. Subsequently, the same
group silence a subset of the alpha-gliadins and demonstrate
reduced reactivities of antibodies (IgG and IgA) from a celiac
disease patient cohort. Marín-Sanz et al. explore the impact
of temperature and nitrogen availability of grain filling in
bread wheat focusing specifically on the gliadin and glutenin
protein fractions.
Shifting to gluten analysis, Panda and Garber review the
use of antibody-based methods for accuracy in the quantitation
of gluten in fermented or hydrolyzed foods and the inherent
challenges due to the lack of appropriate reference materials
and variable proteolysis. Next Alves et al. review the primary
proteomic approaches used in the identification and quantitation
of gluten peptides related to CD-activity and gluten-related
allergies. In a complementary study, Daly et al. describe an update
to the GluPro database, that provides a solid foundation for
proteomic analysis of gluten proteins from gluten containing
cereals. This database will enable identification of peptide
markers for use in new gluten quantitation methods based
on coeliac toxic motifs present in all relevant cereal species.
To this end, Lexhaller et al. characterize and quantify cereal-
specific gluten protein types by LC-MS/MS, allowing known
wheat allergens and celiac disease-active peptides to be identified
and laying the foundation for development of referencematerials.
Subsequently, five wheat cultivars were assessed by Schall et al.
for their use as reference materials wherein their protein content,
protein composition and responses to different ELISA methods
were evaluated.
Osorio et al. examine the ability to detoxify gluten proteins
using “glutenases” and employing site-directed mutagenesis
aimed at the glutamine specific endoprotease from barley
(EP-B2), and a prolyl endopeptidase from Flavobacterium
meningosepticum (Fm-PEP).
From a clinical perspective, Pinto-Sanchez and Bai review
the current strategies for follow up of patients with celiac
disease, describing new tools for monitoring adherence to
the gluten-free diet which could alter patient treatment.
The isolation and purification of oat avenin for clinical
trials aiming to establish the safety of oats in the diets
of those with CD is reported by Tanner et al. Lastly,
the Prolamin Working Group provide recommendations
regarding clinical, analytical and legal aspects of CD,
identifying those areas that require future multidisciplinary
collaborative efforts.
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